Skip to main content
. 2021 Jul 6;10(14):e019167. doi: 10.1161/JAHA.120.019167

Figure 2. Proportion of MRA‐eligible patients with STEMI* with MRA prescription at discharge by calendar year*.

Figure 2

*MRA‐eligible patients with STEMI: Left ventricular ejection fraction ≤40% plus either clinical heart failure or prior history of diabetes mellitus, and without dialysis‐dependent renal dysfunction. n denotes the number of MRA‐eligible patients with STEMI in that year. MRA indicates mineralocorticoid receptor antagonist; and STEMI, ST‐segment–elevation myocardial infarction.